On the 23rd, Osang Healthcare, a company specializing in in vitro diagnostics (IVD), announced that it was the first domestic in vitro diagnostics company to receive Emergency Use Authorization (EUA) from the US FDA for its COVID-19 and influenza combo kit.

The COVID-19 and influenza combo kit is a diagnostic device that can simultaneously detect COVID-19 and influenza A and B. It features multi-color technology that displays two colors, red and blue, improving usability by allowing users to easily distinguish between COVID-19 and influenza A and B infections.

Full article : Osang Healthcare receives FDA emergency use authorization for COVID-19 and influenza combo kit